Curcuma longa Linn. (Turmeric): Phytopharmaceutical Approach from Traditional Knowledge to Conventional Medicine
Abstract
The traditional Indian system of medicine uses turmeric, scientifically known as Curcuma longa Linn. (C. longa). It is a great example of how traditional knowledge about plants has been combined with modern scientific research on medicines. For a long time, turmeric has been used in systems such as Ayurveda, Siddha, and Unani medicine. These systems have shown that turmeric has many health benefits, such as reducing inflammation, fighting free radicals, killing harmful bacteria, and even helping with cancer. The main phytoconstituent (active ingredient) in turmeric is curcumin, along with other compounds such as demethoxycurcumin, bisdemethoxycurcumin, and certain oils such as turmerones. These compounds work by targeting important processes in the body, such as inflammation and cell growth, through pathways like Activated B-Cells, Nuclear Factor kappa B (NF-κB), Mitogen-Activated Protein Kinase (MAPK), and Phosphoinositide 3-kinase (PI3K)/ Protein kinase-B (Akt). New technologies, like eco-friendly ways to extract curcumin, better ways to separate and standardize it, and advanced delivery methods like nanoparticles, have helped make curcumin more stable and easier for the body to use. Clinical studies have shown that turmeric can help with conditions like inflammation, metabolic issues, problems with the brain, and cancer. It is now used not just in traditional remedies but also in health foods, supplements, and conventional drugs. Looking ahead, there are opportunities to create new, better versions of curcumin, use Artificial intelligence (AI) to design medicines, and make herbal mixtures that meet international safety standards.
Keywords: Curcumin, Nanotechnology, Bioavailability, Clinical validation, Nutraceuticals
Keywords:
Curcumin, Nanotechnology, Bioavailability, Clinical validation, NutraceuticalsDOI
https://doi.org/10.22270/jddt.v16i7.7871References
1. Kumar A, Singh R, Sharma P. Curcumin and beyond: a review of turmeric's pharmacological benefits. Int J Pharma Res Anal. 2025;10(3):1077-1089. doi:10.35629/4494-100310771089
2. Rahmani AH, Alsahli MA, Aly SM, et al. Therapeutic implications of curcumin in diabetes mellitus. Adv Exp Med Biol. 2019;1155:47-74. doi:10.1007/978-3-030-19969-5_3
3. Li L, Zhang X, Liu C, et al. Curcumin-loaded nanoparticles for enhanced anticancer efficacy. Colloids Surf B Biointerfaces. 2020;186:110709. doi:10.1016/j.colsurfb.2019.110709
4. Chen X, Zhang L, Hou H, et al. Curcumin-based nanotherapeutics in cancer: Recent advancements and challenges. Pharmacol Res. 2025;189:106652. doi:10.1016/j.phrs.2024.106652
5. Wu C, Yang L, Cai Y, et al. Protective effects of Curcuma longa extract on neurodegenerative diseases: A review of recent trends. Front Neurosci. 2023;17:1120457. doi:10.3389/fnins.2023.1120457
6. Ireson C, Orr S, Jones DJ, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001;61(3):1058-1064.
7. Alkama M, Anas M, Vasiullah, et al. A review on pharmacognostic pharmacological activities of Curcuma longa L. Int J Pharma Res. 2025;31(5):323-335. doi:10.18231/j.ijpra.2025.043
8. Shahbaz M, Nawaz M, Khan AA, et al. Curcumin piperine combinations in the management of arthritis: Clinical observations. Rheumatol Int. 2020;40(8):1265-1272. doi:10.1007/s00296-020-04525-x
9. Chan MM, Huang HI, Fenton MR, Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol. 1998;55(12):1955-1962. doi:10.1016/S0006-2952(98)00114-2
10. Lee HI, Kang J, Lee S, et al. Topical curcumin nanogels for wound healing: Recent breakthroughs and challenges. Int J Nanomedicine. 2022;17:831-843. doi:10.2147/IJN.S349822
11. Ng J, Wang Y, Aung T. Novel turmeric phytosome formulations in eye disorders: An RCT update. Ophthalmol Ther. 2021;10(4):1129-1139. doi:10.1007/s40123-021-00423-9
12. Patel K, Desai M, Shah N. Curcumin in prostate cancer: a systematic review of molecular mechanisms and clinical implications. Phytother Res. 2025;39(5):2456-2468. doi:10.1002/ptr.8234
13. Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006;4(12):1502-1506. doi:10.1016/j.cgh.2006.08.008
14. Laldinchhana, Zonuntluangi, Roy PK, et al. Qualitative and quantitative characterization of curcuminoids extracted from Curcuma longa cultivated in Mizoram, India. Res J Pharm Technol. 2025;18(10):4871-6. doi:10.52711/0974-360X.2025.00702
15. Tian WW, Xiang HM, Tang YP, et al. Curcuma Longa (turmeric): from traditional applications to modern plant medicine research hotspots. Chin Med. 2025;20(1):76. doi:10.1186/s13020-025-01024-8
16. Darmonkow A, Rowe ZEM, Harding SV. Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies. Biomed Pharmacother. 2025;176:116842. doi:10.1016/j.biopha.2025.116842
17. Banik U, Parvin S, Alam MF, Rahman Z. Anti-inflammatory and antioxidant potential of curcumin nanoparticles in arthritis therapy. J Pharm Biomed Anal. 2020;188:113364. doi:10.1016/j.jpba.2020.113364
18. Panahi Y, Khalili N, Hosseini MS, et al. Effects of curcuminoids plus piperine on glycemic status and lipid profiles in type 2 diabetes mellitus: A randomized controlled trial. Complement Ther Med. 2018;33:1-5. doi:10.1016/j.ctim.2017.08.018
19. Ma Q, Wang S, Zhang T, et al. Curcumin alleviates experimental liver injury by antioxidation and anti-inflammatory activity. Biomed Pharmacother. 2016;78:55-61. doi:10.1016/j.biopha.2016.01.068
20. Fuloria S, Mehta J, Chandel A, Sekar M, Rani NNIM, Begum MY, et al. A comprehensive review on the therapeutic potential of Curcuma longa Linn. in relation to its major active constituent curcumin. Front Pharmacol. 2022;13:820806. doi:10.3389/fphar.2022.820806
21. Dudekula MV, Bharadwaj VN, Patel S, Natarajan S, Priyadarisini VB, Natesan S. Unlocking the genetic diversity of Indian turmeric (Curcuma longa L.) through rhizome morphology and curcuminoid content. Sci Rep. 2022;12(1):21390. doi:10.1038/s41598-022-25547-w
22. Li Y, Wang X, Zhang H, et al. Curcumin and multiple health outcomes: critical umbrella review of systematic reviews and meta-analyses. Front Nutr. 2025;12:1276543. doi:10.3389/fnut.2025.1276543
23. Siddiqui IA, Adhami VM, Khan N, et al. Nanochemoprevention by bioactive food components: a perspective. Pharm Res. 2009;26(2):233-236. doi:10.1007/s11095-008-9698-5
24. Lin L, Cui J, Sheng L, et al. Curcumin inhibits hepatitis B virus replication through downregulation of heat shock cognate 70. Acta Pharmacol Sin. 2011;32(8):1031-1038. doi:10.1038/aps.2011.51
25. Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12(3):332-347. doi:10.2174/138945011794474160
26. Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2015;20(3):153-167. doi:10.1186/s12906-015-0643-1
27. Hori Y, Ito N, Tabata Y, et al. Aromatic-turmerone analogs protect dopaminergic neurons through distinct mechanisms independent of microglial inactivation. J Neuroinflammation. 2021;18(1):102. doi:10.1186/s12974-021-02152-9
28. Del Prete D, Millán E, Pollastro F, et al. Turmeric sesquiterpenoids: expeditious resolution, comparative bioactivity, and a new bicyclic turmeronoid. J Nat Prod. 2016;79(2):267-273. doi:10.1021/acs.jnatprod.5b00637
29. Oluwafemi AG, Ajayi OB, Oseni OA. Phytochemical screening, nutritional composition, and antioxidant activities of turmeric (Curcuma longa) found in Ado-Ekiti, Nigeria. J Appl Life Sci Int. 2022;25(1):1-8. doi:10.9734/jalsi/2022/v25i130278
30. Li M, Qian H, Cao L, Yu J, Tao H. Curcuma longa and cardiovascular health: New clinical insights. Front Cardiovasc Med. 2020;7:578510. doi:10.3389/fcvm.2020.578510
31. El-Saadony MT, Abd El-Hack ME, Taha AE, et al. Curcumin, an active component of turmeric: biological activities, nutritional aspects, immunological, bioavailability, and human health benefits. Front Immunol. 2025;16:1603018. doi:10.3389/fimmu.2025.1603018
32. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631-1652. doi:10.1007/s00018-008-7452-4
33. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44(2):97-111. doi:10.1080/10408690490424702
34. Singh R, Verma M. Turmeric in traditional and modern medicine: comparative analysis of pharmacological applications. J Ethnopharmacol. 2025;320:117456. doi:10.1016/j.jep.2025.117456
35. Dutta S, Das D, Ghosh J, et al. Oral bioavailability of curcumin: Problems and promises. Curr Pharm Des. 2010;16(14):1813-1830. doi:10.2174/138161210791516543
36. Bener M, Özyürek M, Güçlü K, Apak R. Optimization of microwave-assisted extraction of curcumin from Curcuma longa L. (turmeric) and evaluation of antioxidant activity in multi-test systems. Rec Nat Prod. 2016;5(9):542-554. doi:10.25135/rnp.49.15.11.097
37. Chhouk K, Wahyudiono, Kanda H, Goto M. Comparison of conventional and ultrasound assisted supercritical carbon dioxide extraction of curcumin from turmeric (Curcuma longa L.). Eng J. 2017;21(5):53-65. doi:10.4186/ej.2017.21.5.53
38. Widmann AK, Wahl MA, Kammerer DR, Daniels R. Supercritical fluid extraction with CO₂ of Curcuma longa L. in comparison to conventional solvent extraction. Pharmaceutics. 2022;14(9):1943. doi:10.3390/pharmaceutics14091943
39. Binello A, Grillo G, Barge A, Cravotto G. A cross-flow ultrasound-assisted extraction of curcuminoids from Curcuma longa L.: process design to avoid degradation. Molecules. 2020;25(12):2848. doi:10.3390/molecules25122848
40. Mandal V, Mohan Y, Hemalatha S. Microwave assisted extraction of curcumin from turmeric rhizomes. J Pharm Biomed Anal. 2007;44(2):322-327. doi:10.1016/j.jpba.2007.02.030
41. Abualhasan MN, Almuhri Z, Abueidda S, et al. A critical review of analytical methods for determination of curcuminoids in turmeric (Curcuma longa L.) and its extracts. Crit Rev Anal Chem. 2019;49(6):519-535. doi:10.1080/10408347.2019.1616505
42. Kwon HL, Chung MS. Pilot-scale subcritical solvent extraction of curcuminoids from Curcuma longa L. Food Chem. 2015;185:58-64. doi:10.1016/j.foodchem.2015.03.114
43. Phattanawasin P, Sotanaphun U, Piyamyong S, et al. Determination of curcuminoid contents in turmeric (Curcuma longa L.) rhizomes by high-performance thin-layer chromatography. HPTLC method development and validation. Herba Pol. 2009;55(4):146-155. doi:10.1016/j.phymed.2009.04.001
44. Tanaka K, Makino Y, Sakamoto S. Application of near-infrared spectroscopy for estimation of total anthocyanins in berry fruits. J Agric Food Chem. 2008;56(3):744-750. doi:10.1021/jf072734p
45. Siregar C, Wulandari R, Dewi A, et al. Application of Fourier transform infrared (FTIR) spectroscopy with multivariate analysis for quantitative analysis of curcuminoid in tablet formulations. J Appl Pharm Sci. 2018;8(9):107-113. doi:10.7324/JAPS.2018.8914
46. Bansal S, Singh K, Sharma GD. Heavy metal contamination in commercial turmeric: Analysis of lead and chromium in commercial turmeric powder samples. Cognition. 2025;7(1):98-110. doi:10.3126/cognition.v7i1.74770
47. Monton C, Sutheerawattananonda M, Chutipaijit S. Microbial contamination of turmeric capsules produced at a secondary government hospital in the northeastern Thailand. Thai J Pharm Sci. 2016;40(2):107-115. doi:10.12982/TJPS.2016.40.2.3
48. Kumar AK, Banswal S. Black turmeric (Curcuma caesia) in traditional Indian medicine: bioactive compounds and therapeutic applications. Int J Sci Res Rev. 2025;14(1):25-37. doi:10.47119/IJSRR.14.1.2025.25-37
49. Sadeghnia HR, Khorasani M, Shafaroodi H, et al. Neuroprotective role of curcumin in ischemia-reperfusion injury. Eur J Pharmacol. 2016;769:121-129. doi:10.1016/j.ejphar.2015.11.045
50. Plaimee P, Weerapreeyakul N, Barusrux S, Johns NP. Anticancer activities of curcumin and essential oils from turmeric. J Basic Clin Physiol Pharmacol. 2020;31(2):1-10. doi:10.1515/jbcpp-2019-0068
51. Srivastava RM, Singh S, Dubey SK, Misra K, Khar A. Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol. 2018;61:287-297. doi:10.1016/j.intimp.2018.06.036
52. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci. 2011;32(6):291-299. doi:10.1016/j.tips.2011.03.002
53. Sahebkar A, Cicero AFG, Simental-Mendía LE, Bajaj S, Banach M. Curcumin dosage and duration of treatment on lipid profile: A systematic review and meta-analysis of randomized controlled trials. J Funct Foods. 2016;24:348-356. doi:10.1016/j.jff.2016.04.007
54. Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS One. 2015;10(3):e0121313. doi:10.1371/journal.pone.0121313
55. Mounce BC, Olsen ME, Vignuzzi M, Denison MR. Curcumin inhibits Zika and Chikungunya virus infection by inhibiting cell binding. Antiviral Res. 2017;142:148-157. doi:10.1016/j.antiviral.2017.03.014
56. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199-225. doi:10.1016/j.canlet.2008.03.009
57. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280(7):5892-5901. doi:10.1074/jbc.M404751200
58. Gong Z, Huang J, Xu B, et al. Curcumin suppresses HBV replication by inhibiting HBV core protein-mediated p62-selective autophagic degradation. Mol Pharm. 2016;13(2):502-514. doi:10.1021/acs.molpharmaceut.5b00795
59. Panahi Y, Hosseini MS, Khalili N, et al. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial. Nutr Metab (Lond). 2015;12:33. doi:10.1186/s12986-015-0031-4
60. Weisberg SP, Leibel R, Tortoriello DV. Proteasomal dysfunction mediates muscle inflammation and insulin resistance in obesity. J Clin Invest. 2008;118(8):2959-2968.
61. Srivastava S, Srivastava KC. Curcumin and cardiovascular diseases: Effects on platelet aggregation and thrombosis. Curr Pharm Des. 2013;19(11):2032-2046. doi:10.2174/138161213805289228
62. Mirzaei H, Nasiri M, Sharifi M, et al. Current trends in the use of curcumin in nanomedicine for cancer therapy. Drug Discov Today. 2017;22(8):1437-1449. doi:10.1016/j.drudis.2017.07.003
63. Sharifi-Rad J, Rayess YE, Rizk AA, et al. Turmeric and curcumin in health and disease prevention: Review. Food Chem. 2020;332:127451. doi:10.1016/j.foodchem.2020.127451
64. Hong Q, Zhang Y, Chen L, et al. Research trajectory and future trends in curcumin related to immunity: a bibliometric analysis. Front Immunol. 2025;16:1389456. doi:10.3389/fimmu.2025.1389456
65. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives - A review. J Tradit Complement Med. 2017;7(2):205-233. doi:10.1016/j.jtcme.2016.05.005
66. Na LX, Zhang YL, Li Y, et al. Curcumin improves insulin resistance in skeletal muscle of rats. Nutrition. 2011;27(7-8):769-774. doi:10.1016/j.nut.2010.08.009
67. Prakash D, Gupta C, Sagar A. Efficacy of curcumin on cardiovascular risk factors: Systematic review. Complement Ther Med. 2018;36:16-26. doi:10.1016/j.ctim.2017.04.008
68. Das S, Poddar P. Nanostructured curcumin for targeted cancer therapy: Recent progress. Mater Today Bio. 2020;7:100075. doi:10.1016/j.mtbio.2020.100075
69. Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011;16(6):4567-4598. doi:10.3390/molecules16064567
70. Panahi Y, Khalili N, Sahebi E, et al. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res. 2014;28(11):1625-1631. doi:10.1002/ptr.5225
71. Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Mol Nutr Food Res. 2017;61(6):1600762. doi:10.1002/mnfr.201600762
72. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 1995;55(2):259-266.
73. Osman S, Sureram S, Jeon J. Clinical-grade curcumin: Regulatory status and future directions. J Funct Foods. 2020;65:103738. doi:10.1016/j.jff.2019.103738
74. Badria FA, Zidan OA. Antioxidant and antimicrobial activities of curcuminoids from Curcuma longa L. J Biochem Mol Biol Biophys. 2004;8(1):1-7.
75. Rahmani AH, Shabanah S, et al. Curcumin in hepatoprotection and detoxification mechanisms. J Ethnopharmacol. 2018;210:47-57. doi:10.1016/j.jep.2017.08.010
76. Kunwar A, Barik A, Mishra B, et al. Biological activities and medicinal properties of Curcuma longa. Adv Exp Med Biol. 2008;595:297-333. doi:10.1007/978-0-387-46401-5_15
77. Rastogi N, Pandey M, Singh S, et al. Curcumin: a potential candidate for cancer prevention. South Asian J Cancer. 2013;2(2):86-89. doi:10.4103/2278-330X.114123
78. Han C, Li Z, Wang J. Liposomal turmeric and metabolic regulation: A systematic review. J Med Food. 2020;23(9):987-995. doi:10.1089/jmf.2019.0129
79. Vaughan-Shaw PG, et al. Anticancer potential of curcumin: preclinical and clinical studies. Nutr Rev. 2018;76(5):418-427. doi:10.1093/nutrit/nux088
80. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010;49(11):1603-1616. doi:10.1016/j.freeradbiomed.2010.09.006
81. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895-2900.
82. Sharma V, Patel N, Gupta R. Recent strategies for enhancing the solubility and dissolution of curcumin: a comprehensive review. Trop J Nat Prod Res. 2025;9(7):3413-3429. doi:10.26538/tjnpr/v9i7.70
83. Begum AN, Jones MR, Lim GP, et al. Curcumin structure-function, bioavailability and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther. 2008;326(1):196-208. doi:10.1124/jpet.108.137211
84. Bamunuarachchi DDA, Senevirathne A, Kim MG, et al. Antioxidant and anti-inflammatory properties of curcuminoids from Curcuma longa in lipopolysaccharide-stimulated macrophages. Int J Mol Sci. 2015;16(12):28662-28675. doi:10.3390/ijms161226218
85. Nelson KM, Dahlin JL, Bisson J, et al. The essential medicinal chemistry of curcumin: Miniperspective. J Med Chem. 2017;60(5):1620-1637. doi:10.1021/acs.jmedchem.6b00975
86. Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. BioFactors. 2013;39(1):2-13. doi:10.1002/biof.1079
87. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull. 2007;30(1):74-78. doi:10.1248/bpb.30.74
88. Amatto PdPG, Chaves L, França SdC, et al. Efficacy of different pharmaceutical forms of Curcuma longa or curcumin in reducing oral mucositis severity and incidence in cancer patients: a systematic review and meta-analysis. Front Pharmacol. 2025;16:1560729. doi:10.3389/fphar.2025.1560729
89. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1A):363-398.
90. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 2000;94(1):79-83. doi:10.1016/0304-3835(95)03829-4
91. Patel K, Gadebucci R, Patel DK. A pharmacokinetic study and critical reappraisal of curcumin formulations: Evaluating optimal plasma concentrations in clinical practice. eLife. 2024;13(1):e87923. doi:10.7554/eLife.87923
92. Raghunathan V, Menon VP. Nanocurcumin in neurodegenerative disease therapeutics: Contemporary advances. Int J Neurosci. 2020;130(6):523-532. doi:10.1080/00207454.2019.1691140
93. Jha S, Singh VK, Verma V, et al. Polyherbal formulation containing turmeric for hypertension: A phase II clinical trial. Integr Med Res. 2020;9(3):100438. doi:10.1016/j.imr.2020.100438
94. Choudhury S, Shende J, Kumar K. Tumor-suppressing properties of turmeric: New findings from omics approaches. Cancer Lett. 2020;495:60-72. doi:10.1016/j.canlet.2020.08.013
95. Fang Z, Zhao Y, Liu T, et al. Enhancing curcumin's therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery. Nanomedicine. 2024;19:102680. doi:10.1016/j.nano.2024.102680
96. Mohammadpour Dariush Z, Mansoor-Pour M, Bayat M, et al. Studying the characteristics of curcumin-loaded liposomal nanoparticles: Physicochemical properties and drug release assessment. Asian Pac J Cancer Prev. 2024;25(5):1539-1547. doi:10.31557/apjcp.2024.25.5.1539
97. Padmanabhan V, Karuppusamy SA, Rajagopal DR, et al. Chyawanprash, an ancient Indian Ayurvedic medicinal food, regulates immune response in zebrafish model of inflammation by moderating inflammatory biomarkers. Front Pharmacol. 2021;12:751576. doi:10.3389/fphar.2021.751576
98. Padhye S, Kunnumakkara AB, Sethi G, Aggarwal BB. Perspectives on therapeutic and preventive properties of turmeric and curcumin. Adv Exp Med Biol. 2007;595:61-70. doi:10.1007/978-0-387-46401-5_3
99. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40-59. doi:10.1016/j.biocel.2008.06.010
100. Panahi Y, Hosseini MS, Khalili N, et al. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Int J Endocrinol Metab. 2017;15(2):e42635. doi:10.5812/ijem.42635
101. Malik U, Bhatia R. Curcumin-loaded nanofibers for diabetic wound management: A translational study. J Biomed Mater Res B Appl Biomater. 2021;109(9):1342-1352. doi:10.1002/jbm.b.34810
102. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med. 2003;9(1):161-168. doi:10.1089/107555303321223035
103. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787-809. doi:10.1016/j.bcp.2007.08.016
104. Baratzadeh F, Yousef Yekta R, Rezaee Z, et al. Effects of curcumin on low-density lipoprotein oxidation: A systematic review and meta-analysis of clinical trials. Molecules. 2022;27(12):3966. doi:10.3390/molecules27123966
105. Li L, Lin J, Gao F, et al. Review of the effects and mechanism of curcumin in the treatment of inflammatory bowel disease. Front Pharmacol. 2022;13:908077. doi:10.3389/fphar.2022.908077
106. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41(13):1955-1968. doi:10.1016/j.ejca.2005.05.009
107. Phan TT, See P, Lee ST, Chan SY. Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J Trauma. 2001;51(5):927-931. doi:10.1097/00005373-200111000-00017
108. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-818. doi:10.1021/mp700113r
109. Zhao J, Liu S, Wang Y, et al. Efficacy of curcumin-based complexes in treating osteoarthritis: A multicenter trial. Phytomedicine. 2022;104:154291. doi:10.1016/j.phymed.2022.154291
110. Hewlings SJ, Kalman DS. Curcumin: A review of its effects on human health. Foods. 2017;6(10):92. doi:10.3390/foods6100092
111. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141-153.
112. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21(21):8370-8377. doi:10.1523/JNEUROSCI.21-21-08370.2001
113. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081-2087. doi:10.1016/j.lfs.2005.12.007
114. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005;1056:206-217. doi:10.1196/annals.1352.010
115. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991;57(1):1-7. doi:10.1055/s-2006-960004
116. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847-6854. doi:10.1158/1078-0432.CCR-04-0744
117. O'Connell CL, Lee K, Komrokji R, et al. Curcumin to improve inflammation and symptoms in patients with clonal cytopenia of undetermined significance, low-risk myelodysplastic syndrome, and myeloproliferative neoplasms. Clin Cancer Res. 2025;31(1):45-56. doi:10.1158/1078-0432.CCR-24-0892
118. Panahi Y, Alishiri GH, Parvin S, Sahebkar A. Mitigation of oxidative stress, inflammation, and muscle damage by curcumin supplementation in healthy active females: A randomized controlled trial. J Diet Suppl. 2016;13(3):430-439. doi:10.1080/19390211.2015.1028748
119. Liao J, Duan Y, Zhu P, et al. Improved anti-inflammatory effects of curcumin via encapsulation in nanocarriers. Nanomedicine. 2015;11(2):397-415. doi:10.1016/j.nano.2014.10.006
120. Holdhoff M, Sordillo P, Himes BT, et al. Phase I/II study of liposomal curcumin in combination with radiation and temozolomide in patients with newly diagnosed high-grade gliomas. Neuro Oncol. 2024;26(5):891-902. doi:10.1093/neuonc/noae041
121. Panahi Y, Rahimi HR, Sahebkar A. Curcuminoid therapy in combination with conventional medication for hypercholesterolemia and atherosclerosis complications. Atherosclerosis. 2024;392:117-127. doi:10.1016/j.atherosclerosis.2024.01.015
122. Wang S, Gao Y, Zhang L, et al. Curcumin combination with piperine enhances the systemic bioavailability and pharmacological effects. Phytomedicine. 2020;73:153085. doi:10.1016/j.phymed.2020.153085
123. Lopresti AL. Curcumin and piperine supplementation on reducing pain and improving physical function in participants with moderate to severe knee osteoarthritis. Clin Interv Aging. 2023;18:1223-1235. doi:10.2147/CIA.S413970
124. Prasad S, Aggarwal BB. Curcumin for reducing side effects of chemotherapy and radiotherapy. Phytother Res. 2021;35(3):1355-1369. doi:10.1002/ptr.6925
125. Safari S, Rahmati B, Tavalaei S, et al. Curcumin effects on chronic obstructive pulmonary disease: A systematic review. Health Sci Rep. 2023;6(3):e1162. doi:10.1002/hsr2.1162
126. Zeng Y, Hong H, Guo Y, et al. Therapeutic effect of curcumin on metabolic diseases. Nutrients. 2023;12(2):476. doi:10.3390/nu12020476
127. Mills S, Bone K. Turmeric (Curcuma longa)-Anti-inflammatory and antimicrobial actions. In: Principles and Practice of Phytotherapy. 1st ed. Edinburgh: Churchill Livingstone; 2000. p. 483-491. doi:10.1016/S0006-2952(98)00114-2
128. Hellmann PW, Weickert MO, Eur C, et al. No effect of the turmeric root phenol curcumin on insulin-induced weight gain and hepatic steatosis: A randomized, double blind, placebo-controlled trial. Nutrients. 2023;12(4):987. doi:10.3390/nu12040987
129. Sedighi S, Eslamian G, Mazidi M, et al. The effects of curcumin supplementation on inflammatory biomarkers in patients with systemic lupus erythematosus. Phytother Res. 2024;38(11):5845-5854. doi:10.1002/ptr.8123
130. Panahi Y, Saeedi M, Akbari H, et al. Curcumin supplementation in kidney transplant recipients: A randomized controlled trial. World J Gastroenterol. 2022;28(42):6135-6149. doi:10.3748/wjg.v28.i42.6135
131. Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, et al. Curcumin in metabolic health and disease. Nutrients. 2021;14(3):520. doi:10.3390/nu14030520
132. Besasie BD, Saha A, DiGiovanni J, Liss MA. Effects of curcumin and ursolic acid in prostate cancer: A systematic review. Prostate Cancer Prostatic Dis. 2024;27(1):66-79. doi:10.1177/03915603231202304
133. Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. J Pharm Pharmacol. 2014;66(4):490-503. doi:10.1111/jphp.12313
134. Brace LD. Impact of curcumin on cardiovascular and metabolic diseases: Preclinical and clinical updates. J Cardiovasc Pharmacol Ther. 2016;21(4):350-362. doi:10.1177/1074248416638964
135. Wei F, Yang H, Zhang H. Curcuma longa and COVID-19: Evidence-based perspectives. J Ethnopharmacol. 2020;259:112978. doi:10.1016/j.jep.2020.112978
136. Al-Dujaili EA, Smail N. Pomegranate juice intake enhances salivary testosterone levels and improves mood and well being in healthy men. Endocr Abstr. 2012;28:313.
137. Singh RG, Dey U, Dey R, et al. Advances in curcumin bioavailability: Effects of novel formulations. J Funct Foods. 2024;112:105625. doi:10.1016/j.jff.2024.105625
138. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J. 2013;15(1):195-218. doi:10.1208/s12248-012-9432-
139. Sethi V, Garg M, Herve M, Mobasheri A. Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis. Ther Adv Musculoskelet Dis. 2022;14:1759720X221124545. doi:10.1177/1759720X221124545
140. Koshikumar A, Jayaprakash A, Aswathy BS, et al. Synergistic anti-inflammatory activity of ginger and turmeric extracts in lipopolysaccharide and interferon-γ-induced murine RAW 264.7 cells. Front Pharmacol. 2022;13:818166. doi:10.3389/fphar.2022.818166
141. Prasad S, Aggarwal BB. Curcumin: Target for signals transduction, transcription factors, and genes implicated in various disorders. Curr Med Chem. 2020;13(16):1891-900. doi:10.2174/0929867067774489
142. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol. 2000;25(6):447-452. doi:10.1111/j.2042-7158.1973.tb09131.x
143. Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci. 2005;50(11):2191-2193. doi:10.1007/s10620-005-3032-8
144. Araujo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001;96(5):723-728. doi:10.1590/S0074-02762001000500026
145. Reddy AC, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem. 1992;111(1-2):117-124. doi:10.1007/BF00229582
146. Patel M, Mehta V. Recent clinical evidence for turmeric and curcumin in managing COVID-19. Phytother Res. 2025;39(1):123-129. doi:10.1002/ptr.7662
147. Pari L, Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacol Res. 2004;49(5):481-486. doi:10.1016/j.phrs.2003.11.005
148. Nirmala C, Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem. 1996;159(2):85-93. doi:10.1007/BF00420910
149. Thapliyal R, Maru GB. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol. 2001;39(6):541-547. doi:10.1016/S0278-6915(00)00165-4
150. Rani K, Satapathy S, Panda S, et al. Curcumin and its nanoformulations in infectious diseases: New avenues for old remedies. J Nanomed Nanotechnol. 2022;13(5):1-10. doi:10.35248/2157-7439.22.13.644
151. Kunnumakkara AB, Bordoloi D, Harsha C, et al. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325-1348. doi:10.1111/bph.13621
152. Lin L, Hu K, Gao Y, et al. Bioactivities of EF24, a novel curcumin analog: A review. Front Oncol. 2018;8:614. doi:10.3389/fonc.2018.00614
153. Jourghanian P, Ghaffari S, Ardjmand M, et al. Sustained release curcumin loaded solid lipid nanoparticles. Int J Pharm. 2016;511(1):406-419. doi:10.1016/j.ijpharm.2016.07.013
154. Zarei M, Aghaei A, Sedighi S, et al. Synergistic effects of metformin and curcumin on gastric cancer cell apoptosis. EXCLI J. 2021;20:1488-1498. doi:10.17179/excli2021-4091
155. Shoba G, Joy D, Joseph T, et al. Bioavailability enhancers of herbal origin: An overview. J Med Food. 2013;16(2):101-111. doi:10.1089/jmf.2012.2276
156. Karthikeyan A, Senthil N, Min T. Nanocurcumin: A promising candidate for therapeutic applications. Molecules. 2020;25(8):1739. doi:10.3390/molecules25081739
157. Han Y, Peng S, Liu Z, et al. Innovative delivery systems for curcumin: Exploring nanosized and advanced formulations. Pharmaceuticals. 2024;17(5):671. doi:10.3390/ph17050671
158. Bahrami H, Alikhani Z, Rahmani D, et al. Molecular docking and in silico screening of novel curcumin derivatives targeting NF-κB and STAT3 pathways. Pharmaceuticals. 2024;17(5):614. doi:10.3390/ph17050614
159. Jamshed H, Hasan AU, Poudyal H, et al. The synergistic and anticancer potential of Withania somnifera (Ashwagandha) and its active components in combination therapy. J Integr Med. 2024;22(4):e1054. doi:10.1016/j.joim.2024.04.005
160. Cecchin E, Stocco G. Pharmacogenomics and personalized medicine. Genes (Basel). 2020;11(6):679. doi:10.3390/genes11060679
161. Murtaza H, Ahmed S, Khan MA, et al. Green synthesized (Curcuma longa) Ni nanoparticles doped chitosan and PEG for wound healing and anti-bacterial activity. Int J Biol Macromol. 2025;259:129847. doi:10.1016/j.ijbiomac.2025.129847
162. Xie W, Wu L, He Z. Recent updates on the pharmacokinetics of curcumin: Approaches to overcome challenges. Expert Opin Drug Metab Toxicol. 2021;17(8):911-926. doi:10.1080/17425255.2021.1956089
163. Verma N, Kumari R, Yadav D. Synergistic effects of turmeric and conventional drugs in clinical management of cancer. Curr Drug Targets. 2022;23(9):873-882. doi:10.2174/1389450123666220506102323
164. Tripathi S, Sahoo A, Rath S, et al. Curcumin and metabolic syndrome: Ongoing updates from recent research. Nutrients. 2023;15(11):2212. doi:10.3390/nu15112212
165. Barreto RS, Quintans-Junior LJ, Saavedra LM, et al. Therapeutic potential of turmeric in age-related disorders: A translational review. Ageing Res Rev. 2020;63:101135. doi:10.1016/j.arr.2020.101135
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Md. Quamuddin , Anu Sharma, Pinki Gupta, Komal Bhati, Rajan Chauhan, Rohit Kumar, Saurabh Nimesh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.